Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. CDLX
  6. >
  7. Earnings
stocks logo

CDLX Earnings

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings

Earning Analysis

Welcome to our in-depth analysis of Cardlytics Inc(CDLX) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Cardlytics Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.

Earnings Forecast

Revenue
EPS
Currency: USD
Actual
Estimate

Surprise Analysis

Name
EPS
Revenue
Price Reaction
Fiscal QuarterEarning DateTimeEstimateActualSurprise%EstimateActualSurprise%1D5D
Fiscal Quarter
Earning Date
Time
Estimate
Actual
Surprise%
Estimate
Actual
Surprise%
1D
5D
FY2025Q32025-11-05After Hours-0.23-0.07+69.5754.54M52.03M-4.60-28.41-16.48
FY2025Q22025-08-06After Hours-0.16-0.13+18.7564.02M63.25M-1.20-26.14-28.98
FY2025Q12025-05-07After Hours-0.27-0.21+22.2258.01M61.90M+6.70-12.04-2.78
FY2024Q42025-03-12After Hours-0.200.01+105.0063.63M74.00M+16.30+4.55+15.15
FY2024Q22024-08-07After Hours-0.50--75.37M69.64M-7.61-57.10-46.52
FY2024Q12024-05-08---0.35-71.69M67.61M-5.70-5.26-38.42
FY2023Q42024-03-14---0.14-89.55M89.17M-0.43-4.83+76.86
FY2023Q22023-08-01--0.67-0.57+14.9369.07M76.70M+11.05-3.43+26.22
-2023-05-04--0.69-0.47+31.88---+1.72-23.80
-2023-03-01--0.72-0.66+8.33----2.39-13.03
AI Stock Picker
AI Stock Picker

CDLX Earnings Analysis

Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Cardlytics Inc reported performance for FY2025Q3, announced on 2025-11-05. The company achieved an EPS of -0.07, compared to analyst estimates of -0.23 by 69.57% . Revenue for the quarter reached 52.03M compared to expectations of 54.54M by -4.60% .
The stock price reacted with a -28.41% one-day change and a -16.48% five-day change following the earnings release. These movements reflect market reaction in Cardlytics Inc growth trajectory and strategic initiatives.

CDLX Earnings Forecast

Looking ahead, Cardlytics Inc(CDLX) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q4 project quarter revenue of 56.32M and an EPS of -0.10.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Downward by -1.68%, while EPS estimates have been Revise Downward by -7.76%. For the upcoming Q4 2025, revenue estimates have been adjusted Revise Downward by -6.6% . These revisions correlate with a 29.80% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Cardlytics Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.

Estimate Revision

The chart shows the correlation between CDLX's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Downward
down Image
-1.68%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-7.76%
In Past 3 Month
Revenue Estimates for Q4 2025
Revise Downward
down Image
-6.6%
In Past 3 Month
Stock Price
Go Up
up Image
+29.80%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:232.79M
--
EPS Estimate-Annual FY 2025:-0.54
—
Stock Price1.21
Financial AI Agent
Financial AI Agent

CDLX Revenue and EPS Performance: A Historical Perspective

Cardlytics Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q3 (2025-11-05,After Hours):
EPS: -0.07 (Actual) vs.-0.23 (Estimate) (69.57%)
Revenue: 52.03M (Actual) vs. 54.54M (Estimate) (-4.60%)
Price Reaction: -28.41%(1-Day), -16.48%(5-Day)
FY2025Q2 (2025-08-06,After Hours):
EPS: -0.13 (Actual) vs.-0.16 (Estimate) (18.75%)
Revenue: 63.25M (Actual) vs. 64.02M (Estimate) (-1.20%)
Price Reaction: -26.14%(1-Day), -28.98%(5-Day)
FY2025Q1 (2025-05-07,After Hours):
EPS: -0.21 (Actual) vs.-0.27 (Estimate) (22.22%)
Revenue: 61.90M (Actual) vs. 58.01M (Estimate) (6.70%)
Price Reaction: -12.04%(1-Day), -2.78%(5-Day)
Earnings Reaction
The chart below shows how CDLX performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CDLX sees a +8.71% change in stock price 10 days leading up to the earnings, and a -13.96% change 10 days following the report. On the earnings day itself, the stock moves by -2.44%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed -28.41% on the day following the earnings release and then changed by -31.25% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Intellectia AI SwingMax
Intellectia AI SwingMax

Transcript Summary

Cardlytics Inc (CDLX) Q3 2025 Earnings Call Summary
Negative
2025-11-05
The earnings call reveals significant challenges: a loss of a major FI partner, a 20.3% decline in billings, and a 22.4% drop in revenue. Despite some positive aspects, like improved adjusted EBITDA and U.K. growth, the dependence on new partnerships and economic uncertainties pose risks. The Q&A didn't alleviate concerns, as explanations confirmed ongoing margin pressures and uncertainties in guidance. These factors, along with the lack of a market cap, suggest a negative sentiment, anticipating a stock price decline of -2% to -8%.
Cardlytics Inc (CDLX) Q2 2025 Earnings Call Summary
Negative
2025-08-06
The earnings call reveals several negative indicators: a 9.2% revenue decline, decreased revenue to billings margin, and ongoing pressures on advertiser performance. Despite some positive elements like increased U.K. revenue and positive adjusted EBITDA, the Q&A highlights significant concerns about FI partner restrictions affecting billings and unclear management responses. The guidance for Q2 2025 further indicates a potential decline. These factors suggest a negative sentiment, likely resulting in a stock price decrease between -2% to -8% over the next two weeks.
Cardlytics Inc (CDLX) Q1 2025 Earnings Call Summary
Negative
2025-05-07
The earnings call revealed several negative aspects: declining financial performance, cautious advertiser spending due to macroeconomic uncertainty, and a workforce reduction. Despite some positive elements like increased MQUs and engagement-based pricing, the overall sentiment is negative due to liquidity concerns, negative EBITDA, and a lack of clear guidance on future opportunities. The Q&A section highlighted management's reluctance to provide specifics, further contributing to uncertainty. These factors suggest a negative stock price movement in the short term.
Cardlytics Inc (CDLX) Q4 2024 Earnings Call Summary
Negative
2025-03-13
The earnings call reveals several concerning factors: a missed EPS expectation, declining revenue, and a negative growth outlook for Q1. Despite some positive developments like new partnerships and improved delivery, the lack of a share buyback or dividend program, coupled with weak guidance and cautious financial health, suggests a negative sentiment. The Q&A section highlighted management's vague responses, particularly regarding Dosh's contributions and micro-targeting opportunities, further dampening confidence.
Cardlytics Inc (CDLX) Q4 2024 Earnings Call Summary
Negative
2025-03-12
The earnings call revealed several negative factors, including a decline in total billings and revenue, liquidity concerns, and a decrease in Bridg revenue due to the loss of key accounts. While there is optimism about new partnerships and improvements in delivery performance, the lack of a share buyback program and the weak Q4 guidance suggest challenges ahead. Additionally, the Q&A session highlighted economic uncertainties affecting advertiser mentality. These factors, combined with a lack of clear guidance, contribute to a negative sentiment rating, suggesting a potential stock price decline of -2% to -8% over the next two weeks.
Cardlytics Inc (CDLX) Q4 2024 Earnings Call Summary
Negative
2025-03-12
The earnings call summary presents a mixed picture with several negative indicators. Financial performance shows a significant year-over-year decline in revenue and billings, and weak guidance with a negative adjusted EBITDA for Q1. Despite some positive aspects, like UK revenue growth and liquidity, the overall sentiment is negative due to declining margins, reduced U.S. revenue, and negative free cash flow. The Q&A reveals concerns about economic uncertainties and unclear management responses, further dampening sentiment. The lack of a new partnership announcement or strong guidance adjustments also contributes to a negative outlook.
Cardlytics, Inc. (CDLX) Q3 2024 Earnings Call Summary
Negative
2024-11-07
The earnings call summary indicates several negative factors: declining revenue and adjusted EBITDA, negative guidance for Q3 billings, and a lack of a shareholder return plan. The Q&A session highlights concerns about under-delivery and management's reluctance to provide clear guidance. While there are positive aspects, such as the UK revenue increase and new partnerships, the overall sentiment is negative due to competitive pressures, economic challenges, and client retention issues. The stock price is likely to decline by -2% to -8% over the next two weeks.
Cardlytics, Inc. (CDLX) Q2 2024 Earnings Call Summary
Negative
2024-08-08
The earnings call and Q&A reveal several concerns: a decline in revenue, reduced billings growth expectations for 2024, and CEO transition risks. Despite positive adjusted EBITDA and cash flow, the absence of a share repurchase program, competitive pressures, and technology platform challenges weigh negatively. The Q&A highlights delivery issues and lack of clear timelines for resolution, further contributing to negative sentiment. Overall, the company's outlook and recent performance suggest a negative stock reaction in the short term.

People Also Watch

FAQ

arrow icon

What were the key highlights of CDLX’s latest earnings report for FY2025Q3?

CDLX reported its FY2025Q3 earnings on 2025-11-05, showcasing a revenue of 52.03M against an estimate of 54.54M, resulting in a -4.6% surprise. The EPS was -0.07, surpassing the expected -0.23 by 69.57% . The stock experienced a -28.41% price change on the earnings day and a -16.48% change over the next five days, reflecting market reactions to the results.
arrow icon

How did CDLX’s stock price react after the FY2025Q3 earnings release?

Following CDLX’s FY2025Q3 earnings announcement on 2025-11-05, the stock price moved by -28.41% on the day of the release. Over the subsequent five days, it saw a -16.48% change. Historically, CDLX’s stock price tends to shift by an average of +8.71% in the 10 days leading up to earnings and -13.96% in the 10 days following, providing insight into potential market.
arrow icon

What are the revenue and EPS estimates for CDLX for 2025/Q4?

For 2025/Q4, analysts estimate CDLX’s annual revenue to reach 56.32M, while the EPS is projected at -0.10. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -1.68% and EPS estimates Revise Downward by -6.6% over the past three months, indicating analyst expectation in the company’s performance.
arrow icon

How does CDLX’s stock price correlate with earnings forecast revisions?

The correlation between CDLX’s stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -1.68%, while EPS estimates moved Revise Downward by -6.6% . This trend suggests that price dips could present buying opportunities for investors.
arrow icon

What should investors expect from CDLX’s next earnings report?

Based on historical trends, CDLX’s stock price typically moves by +8.71% in the 10 days before its earnings and -13.96% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -0.10 and revenue of 56.32M.
arrow icon

What is the sentiment in Cardlytics Inc (CDLX) Q3 2025 Earnings Call Summary?

The earnings call reveals significant challenges: a loss of a major FI partner, a 20.3% decline in billings, and a 22.4% drop in revenue. Despite some positive aspects, like improved adjusted EBITDA and U.K. growth, the dependence on new partnerships and economic uncertainties pose risks. The Q&A didn't alleviate concerns, as explanations confirmed ongoing margin pressures and uncertainties in guidance. These factors, along with the lack of a market cap, suggest a negative sentiment, anticipating a stock price decline of -2% to -8%.
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free